Skip to Main Content

Previous Day's Reflection     Next Day's Reflection     Go to Today's Reflection

Opportunity or Criticism: “Yeah, but …”

Sunday, July 7, 2013

Fourteenth Sunday in Ordinary Time

“The seventy-two returned rejoicing, and said, ‘Lord, even the demons are subject to us because of your name.’ Jesus said ... ‘Nevertheless do not rejoice because the spirits are subject to you, but rejoice because your names are written in heaven.’” (Luke 10:17, 20)

Oh the excitement, awe and wonder the 72 must have experienced when they realized their new-found power and authority. What they had done was as unthinkable as a turtle winning a race against a jack rabbit!

As I prayed with today’s Gospel, even I could sense the rise and fall of the energy in the scene. I could hear the laughter and the storytelling as they walked toward Jesus, one after another speaking more emphatically and confidently about what he or she had been able to do — and with so little effort! They were walking on air, oozing confidence and glee. And just when they were at the apex, Jesus put their feet back on the ground.

Much like a performance review, he does what any leader who truly cares about an associate’s growth would do — affirms and suggests deeper truth. “Yeah, but …” Depending upon where one’s true north is, Jesus’ words will be received as an opportunity for improvement or criticism of the “Yeah, but …” variety.


Keeper of the Book of Life,

When we experience the awe of power and authority,

or the agony that comes with reframing an opportunity with criticism

give us the wisdom and humility to remember

we would have none of it without Your love. Amen.

Sister Roxanne Seifert
Vice President of Mission, Avera Queen of Peace Hospital

ISAIAH 66:10-14C ● PSALM 66:1-3, 4-5, 6-7, 16, 20 • GALATIANS 6:14-18 ● LUKE 10:1-12, 17-20 OR LUKE 10:1-9

Prayers in Time of Illness

collection of prayers appropriate for times of illness. 

Subscribe to a
daily reminder.

Enter your email address:
Yes, I would like to
be sent additional
information about Avera.